Serum biomarker

Serum biomarkers are defined as substances changing quantitatively in the serum during tumor development. Classically, a marker is synthesized by the tumor and released into circulation or expressed at the cell surface in large quantity by malignant cells.

• Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort
• The potential impact of clindamycin on neurosurgery patients: a randomized controlled trial
• MicroRNA- 103 as a novel potential biomarker of poor prognosis and durg resistance in solid tumours
• Association between multiple serum biomarkers and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage
• Glucose-potassium ratio: a prognostic biomarker enhancing outcome prediction in mild-to-moderate traumatic brain injury
• Prediction of outcomes following intravenous thrombolysis in patients with acute ischemic stroke using serum UCH-L1, S100beta, and NSE: a multicenter prospective cohort study employing machine learning methods
• Clinical utility of GAL-8, ITGbeta-1, and HIF-1alpha as non-invasive diagnostic and prognostic biomarkers for assessing glioma
• Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis